CRISPR Therapeutics (CRSP) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.58
-1.2
-0.82
-0.44

Details

Expected EPS
-1.243557
Actual EPS
-1.58
Surprise EPS
-0.34
Surprise Percent
-27.05%

Description

⁨CRISPR Therapeutics⁩ (⁦CRSP⁩) has reported earnings of ⁦-1.58⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts